All In Biotech

Drug Trial Radar · NCT02908958

Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Children Growth Hormone Deficiency: A Multicenter, Randomized, Parallel, Dose-control Clinical Trial II

Last checked: Nov 19, 2026Latest source record: Jun 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 900 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

900

Planned (sponsor's estimate)

Start

Nov 2014

Primary completion

Jun 2017

Sponsor

Sponsor type
Industry
Collaborators
The Children's Hospital of Zhejiang University School of Medicine; The Second Hospital of Anhui Medical University; Guangzhou Women and Children's Medical Center; First People's Hospital of Hangzhou; Qilu Hospital of Shandong University; Zhejiang Provincial People's Hospital; Zhejiang Provincial Hospital of TCM; Central South University; Southwest Hospital, China; First Affiliated Hospital of Guangxi Medical University; Shanghai Children's Medical Center; Second Affiliated Hospital of Wenzhou Medical University; The First Affiliated Hospital of Xiamen University; Third Affiliated Hospital, Sun Yat-Sen University; Xiangya Hospital of Central South University; Shaoxing Second Hospital
First posted
Sep 21, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 3 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of PEG Somatropin Injection (Jintrolong®) in the treatment of short stature due to endogenous growth hormone deficiency (GHD) in the broad of population of children.

Conditions

  • Growth Hormone Deficiency

Interventions

  • PEG-somatropinBiological

    High dose group: PEG Somatropin 0.2 mg/kg/w, subcutaneous use, inject once a week, the duration is for 26 weeks.

  • PEG-somatropinBiological

    Low dose group: PEG Somatropin 0.14 mg/kg/w, subcutaneous use, inject once a week, the duration is for 26 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The change of Height Standard Deviation Score for Chronological Age before and after the treatment (ΔHtSDSCA)Time frame: 26 weeks

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Southwest Hospital, Third Military Medical University

    Chongqing, China · Recruiting

  • Shanghai Children's Medical Center

    Shanghai, China · Recruiting

  • The Second Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Wuhu No.1 People's Hospital

    Wuhu, Anhui, China · Recruiting

  • The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China · Recruiting

  • Guangzhou Women and Children's Medical Center

    Guangzhou, Guangdong, China · Recruiting

  • The Third Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • Harbin Children's Hospital

    Harbin, Heilongjiang, China · Recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

  • Xiangya Hospital, Central South University

    Changsha, Hunan, China · Recruiting

  • Children's Hospital of Changchun

    Changchun, Jilin, China · Recruiting

  • Qilu Children's Hospital of Shandong University

    Jinan, Shandong, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Recruiting

  • Chengdu Women and Children's Central Hospital

    Chengdu, Sichuan, China · Recruiting

  • Hangzhou First People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • The Children's Hospital ,Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

  • Zhejiang Provincial Hospital of Traditional Chinese Medcine Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • Ningbo Women and Children's Hospital

    Ningbo, Zhejiang, China · Recruiting

  • Shaoxing Second Hospital

    Shaoxing, Zhejiang, China · Recruiting

  • The Second Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.